Clinical Trial Update: Evaluation of Amphotericin B in the Treatment of Biopsy Proven Candida Esophagitis in Immunocompromised Patients [NA]

View source ↗

Summary

This clinical trial update reports on evaluating amphotericin B for biopsy-proven esophageal candidiasis in immunocompromised patients; the study status is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Candidiasis
• HIV Infection

Drugs mentioned

• Amphotericin B (Amphotericin B)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Candidiasis, Esophageal, HIV Infections | NA | Status: COMPLETED